Showing 1 to 3 of 3 results


Proteomics Secures $4.5M to Launch Novel Diagnostic Blood Tests
Proteomics International Laboratories secured $4.5 million to launch three novel blood tests (PromarkerD, PromarkerEso, PromarkerEndo) across Australia and the US, aiming to address significant unmet needs in diabetic kidney disease, oesophageal cancer, and endometriosis diagnosis.
Proteomics Secures $4.5M to Launch Novel Diagnostic Blood Tests
Proteomics International Laboratories secured $4.5 million to launch three novel blood tests (PromarkerD, PromarkerEso, PromarkerEndo) across Australia and the US, aiming to address significant unmet needs in diabetic kidney disease, oesophageal cancer, and endometriosis diagnosis.
Progress
48% Bias Score


Mother Gives Birth While on Dialysis, Defying Rare Odds
Tendai Chisambara, 36, gave birth to her son Zane in January 2023 while undergoing dialysis for chronic kidney disease, defying odds given that only 584 similar cases occurred worldwide between 2008 and 2014.
Mother Gives Birth While on Dialysis, Defying Rare Odds
Tendai Chisambara, 36, gave birth to her son Zane in January 2023 while undergoing dialysis for chronic kidney disease, defying odds given that only 584 similar cases occurred worldwide between 2008 and 2014.
Progress
24% Bias Score

Delayed Kidney Disease Diagnosis Highlights UK Healthcare Issue
Becky Bessell's delayed diagnosis of nephrotic syndrome, a kidney disease, highlights the UK's widespread problem of late CKD detection, emphasizing the need for accessible and timely testing to prevent irreversible damage.

Delayed Kidney Disease Diagnosis Highlights UK Healthcare Issue
Becky Bessell's delayed diagnosis of nephrotic syndrome, a kidney disease, highlights the UK's widespread problem of late CKD detection, emphasizing the need for accessible and timely testing to prevent irreversible damage.
Progress
28% Bias Score
Showing 1 to 3 of 3 results